Literature DB >> 17171334

Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background.

Simon Gengler1, Victor A Gault, Patrick Harriott, Christian Hölscher.   

Abstract

The aggregation of beta-amyloid to plaques in the brain is one of the hallmarks of Alzheimer disease (AD). Numerous studies have tried to elucidate to what degree amyloid peptides play a role in the neurodegenerative developments seen in AD. While most studies report an effect of amyloid on neural activity and cognitive abilities of rodents, there have been many inconsistencies in the results. This study investigated to what degree the different genetic backgrounds affect the outcome of beta-amyloid fragment (25-35) on synaptic plasticity in vivo in the rat hippocampus. Two strains, Wistar and Lister hooded rats, were tested. In addition, the effects of a strong (600 stimuli) and a weak stimulation protocol (100 stimuli) on impairments of LTP were analysed. Furthermore, since the state of amyloid aggregation appears to play a role in the induction of toxic processes, it was tested by dual polarisation interferometry to what degree and at what speed beta-amyloid (25-35) can aggregate in vitro. It was found that 100 nmol beta-amyloid (25-35) injected icv did impair LTP in Wistar rats when using the weak but not the strong stimulation protocol (P < 0.001). One-hundred nano mole of the reverse sequence amyloid (35-25) had no effect. LTP in Lister Hooded rats was not impaired by amyloid at any stimulation protocol. The aggregation studies showed that amyloid (25-35) aggregated within hours, while amyloid (35-25) did not. These results show that the genetic background and the stimulation protocol are important variables that greatly influence the experimental outcome. The fact that amyloid (25-35) aggregated quickly and showed neurophysiological effects, while amyloid (35-25) did not aggregate and did not show any effects indicates that the state of aggregation plays an important role in the physiological effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171334     DOI: 10.1007/s00221-006-0819-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   2.064


  52 in total

1.  Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).

Authors:  Nigel Irwin; Victor A Gault; Brian D Green; Brett Greer; Patrick Harriott; Clifford J Bailey; Peter R Flatt; Finbarr P M O'Harte
Journal:  Biol Chem       Date:  2005-07       Impact factor: 3.915

2.  Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits.

Authors:  A Stéphan; S Laroche; S Davis
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

3.  Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression.

Authors:  J Johannesen; F Pociot; A E Karlsen; T Mandrup-Poulsen; J Nerup
Journal:  Eur Cytokine Netw       Date:  2001 Jul-Sep       Impact factor: 2.737

4.  Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.

Authors:  Milla Koistinaho; Mikko I Kettunen; Gundars Goldsteins; Riitta Keinänen; Antero Salminen; Michael Ort; Jan Bures; David Liu; Risto A Kauppinen; Linda S Higgins; Jari Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

Authors:  Rebecca Radde; Tristan Bolmont; Stephan A Kaeser; Janaky Coomaraswamy; Dennis Lindau; Lars Stoltze; Michael E Calhoun; Fabienne Jäggi; Hartwig Wolburg; Simon Gengler; Christian Haass; Bernardino Ghetti; Christian Czech; Christian Hölscher; Paul M Mathews; Mathias Jucker
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

6.  Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.

Authors:  James P Cleary; Dominic M Walsh; Jacki J Hofmeister; Ganesh M Shankar; Michael A Kuskowski; Dennis J Selkoe; Karen H Ashe
Journal:  Nat Neurosci       Date:  2004-12-19       Impact factor: 24.884

7.  Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety.

Authors:  B Bert; H Fink; R Sohr; A Rex
Journal:  Pharmacol Biochem Behav       Date:  2001 Oct-Nov       Impact factor: 3.533

8.  A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil.

Authors:  D B Freir; D A Costello; C E Herron
Journal:  J Neurophysiol       Date:  2003-02-05       Impact factor: 2.714

Review 9.  Does my mouse have Alzheimer's disease?

Authors:  J C Dodart; C Mathis; K R Bales; S M Paul
Journal:  Genes Brain Behav       Date:  2002-08       Impact factor: 3.449

10.  Dual-polarization interferometry: an analytical technique to measure changes in protein structure in real time, to determine the stoichiometry of binding events, and to differentiate between specific and nonspecific interactions.

Authors:  Marcus J Swann; Louise L Peel; Simon Carrington; Neville J Freeman
Journal:  Anal Biochem       Date:  2004-06-15       Impact factor: 3.365

View more
  7 in total

1.  Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.

Authors:  Yu-Fang Cheng; Chuang Wang; Huan-Bing Lin; Yun-Feng Li; Ying Huang; Jiang-Ping Xu; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

2.  β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition.

Authors:  Adrienne L Orr; Jesse E Hanson; Dong Li; Adam Klotz; Sarah Wright; Dale Schenk; Peter Seubert; Daniel V Madison
Journal:  Neuron       Date:  2014-06-18       Impact factor: 17.173

3.  Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells.

Authors:  Theodora Panagaki; Maria Michael; Christian Hölscher
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

4.  AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.

Authors:  A Borreca; V Latina; V Corsetti; S Middei; S Piccinin; F Della Valle; R Bussani; M Ammassari-Teule; R Nisticò; P Calissano; G Amadoro
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

5.  Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic protein loss in a rat Abeta-infusion Alzheimer's disease model.

Authors:  Aynun N Begum; Fusheng Yang; Edmond Teng; Shuxin Hu; Mychica R Jones; Emily R Rosario; Walter Beech; Beverly Hudspeth; Oliver J Ubeda; Greg M Cole; Sally A Frautschy
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

6.  Abeta mediated diminution of MTT reduction--an artefact of single cell culture?

Authors:  Raik Rönicke; Anja Klemm; Jessica Meinhardt; Ulrich H Schröder; Marcus Fändrich; Klaus G Reymann
Journal:  PLoS One       Date:  2008-09-18       Impact factor: 3.240

7.  Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31-35) and Aβ(25-35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations.

Authors:  Wojciech Chrobak; Dawid Wojciech Pacut; Fredrik Blomgren; Alexander Rodin; Jan Swenson; Inna Ermilova
Journal:  ACS Chem Neurosci       Date:  2021-02-05       Impact factor: 4.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.